Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P20366 (substance P)
 21,176 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The neuropeptide field has witnessed considerable research interest over the past decade, and a growing body of anatomic, biochemical, and electrophysiologic data have since emerged, supporting the existence and putative neuromodulatory function of a large variety of these peptide hormones in several extrahypothalamic brain regions. It is now evident that neuropeptides not only fulfill criteria required of putative neurotransmitters, but more generally act as modulators of neuronal activity. The author discusses vasopressin and oxytocin pathways, corticotropin releasing factor, atrial natriuretic factor, thyrotropin releasing hormone, somatostatin, motilin, growth hormone releasing factor, dopamine, gonadotropin releasing hormone, and substance P.
 ...
PMID:Chemical anatomy of the hypothalamus. 243 89

In a previous study (Watts et al., '87) we reexamined the projections of the suprachiasmatic nucleus (SCh) with the PHA-L method and found that they could be divided conveniently into six groups of fibers. By far the densest projection ends just dorsal to the SCh in a comma-shaped region designated the "subparaventricular zone," although some fibers continue on through the paraventricular nucleus of the hypothalamus to end in the overlying midline thalamus, and others continue on to end in the dorsomedial nucleus, the region around the ventromedial nucleus, and the posterior hypothalamic area. Other relatively sparse projections from the SCh were also described to the preoptic region, lateral septal nucleus, parataenial and paraventricular nuclei of the thalamus, and ventral lateral geniculate nucleus. In addition, the same method was used to show that the subparaventricular zone projects in turn massively to these same regions, as well as back to the SCh itself and to the periaqueductal gray. The present series of experiments was designed to confirm these observations with retrograde tracer injections and to investigate the cellular and possible neurotransmitter organization of the major projections from the SCh and subparaventricular zone with a combined retrograde tracer-immunohistochemical method. For this, the distribution of neuronal cell bodies within the SCh that stain with antisera to vasopressin, vasoactive intestinal polypeptide (VIP), corticotropin-releasing factor, bombesin, substance P, neurotensin, somatostatin, thyrotropin-releasing hormone, and angiotensin II was described in detail first. Then the distribution of retrogradely labeled neurons that were also stained for one or another of these peptides was described after injections of true blue, or in some cases SITS, into the regions of the subparaventricular zone, the paraventricular and parataenial nuclei of the thalamus, the ventromedial nucleus, the dorsomedial nucleus, and the periaqueductal gray. The results confirm previous immunohistochemical and anterograde tracing studies and in addition indicate that cells in dorsal as well as ventral parts of the SCh project to each of the terminal fields examined, as do many cells in surrounding areas, including the subparaventricular zone. Our results also suggest that, at the very least, vasopressin-, VIP-, and neurotensin-stained cells in the SCh project to the subparaventricular zone, midline thalamus, and dorsomedial nucleus, and that the vasopressin and VIP-stained fiber systems are partially segregated at the level of the subparaventricular zone.(ABSTRACT TRUNCATED AT 400 WORDS)
 ...
PMID:Efferent projections of the suprachiasmatic nucleus: II. Studies using retrograde transport of fluorescent dyes and simultaneous peptide immunohistochemistry in the rat. 243 9

A large number of neuropeptides have been found in cortical neurons. They are therefore of interest in attempting to demonstrate selective vulnerability of different populations of neurons in Alzheimer's disease (AD). The most consistent neuropeptide deficit in AD is reductions in cortical concentrations of somatostatin. Lesser reductions in corticotropin-releasing factor, neuropeptide Y and substance P have been reported. Concentrations of both vasoactive intestinal polypeptide and cholecystokinin are relatively preserve. The morphologic correlate of reduced somatostatin concentrations in AD appears to be markedly distorted and reduced terminal fiber plexuses, rather than reduced numbers of neuronal perikarya. A large number of neuropeptides have been localized in senile plaques.
 ...
PMID:Neuropeptides in Alzheimer's disease. 244 13

Alzheimer's disease (AD) is one of more than 60 disorders that may produce dementia. It is characterized clinically by memory deficits and by the presence of aphaso-apracto-agnosic disorders. In the general population, AD has an incidence of 0.3 to 1% and is very common in the elderly (more than 50% of dementia cases). The pattern of pathological changes in the brain in AD is relatively specific. Neuritic plaques, neurofibrillary tangles and cell loss, occur primarily in the cerebral neocortex and hippocampus. On the other hand, neurochemical deficiencies related to the illness have now been identified. The vulnerability of the cholinergic system of the basal nucleus of Meynert was first documented. Following the discovery of the cholinergic reduction in AD and among a dozen of neurotransmitter systems involved in AD, somatostatin, substance P, neuropeptide Y, corticotropin releasing factor and amino acid glutamate were investigated and are the most affected in AD. Results of previous publications and our own investigations are presented here.
 ...
PMID:[Neuromodulators and Alzheimer's disease]. 246

The distribution and morphology of adenosine deaminase, substance P, leucine-enkephalin, corticotropin-releasing factor, and calcitonin gene-related peptidelike immunoreactive cells and fibers throughout the superior colliculus of the rat were examined by means of the unlabelled-antibody peroxidase-antiperoxidase method. Adenosine deaminase immunoreactive cells were found in the stratum opticum and lower stratum griseum superficiale; substance P immunoreactive cells were localized to the upper stratum griseum superficiale, and calcitonin gene-related peptide immunolabelled neurons were situated in deeper strata. Substance P, leucine-enkephalin, and calcitonin gene-related peptide immunoreactive fibers were distributed similarly in their lamination and in their patchlike organization. Corticotropin-releasing factor immunoreactive fibers were observed evenly throughout all the strata and were fewer in the stratum griseum superficiale. These findings suggest that, as in afferent modules and segregated efferents of the mammalian superior colliculus, the cells and fibers containing neuroactive substances and neuroactive substance-related enzymes also show a segregated and laminar distribution.
 ...
PMID:Laminar and segregated distribution of immunoreactivities for some neuropeptides and adenosine deaminase in the superior colliculus of the rat. 246 26

The morphological characteristics of peptide-immunoreactive neurons in the rat central nucleus of the amygdala were examined. Observations were compared with details of neuron morphology available from Golgi-stained tissue to determine whether peptide immunoreactivity was associated with specific cell types in the central nucleus. The lateral subdivision (CL) of the central nucleus contained mainly medium-sized, densely spiny neurons. Larger, pyramiform spiny neurons; medium-sized, sparsely spinous neurons; and small, aspinous cells were also present in CL. Somatostatin-, neurotensin-, corticotropin-releasing factor (CRF)-, and enkephalin-immunoreactive neurons in CL were characterized as the medium spiny and larger, pyramiform types. No obvious morphological differences were evident among medium spiny neurons containing different peptides. In the medial subdivision, substance P, neurotensin, somatostatin, and CRF were present within pyramiform, sparsely spinous neurons with long dendrites. Galanin immunoreactivity in the medial subdivision was associated with moderately spiny, pyramiform neurons and a larger, aspinous, polygonal neuron. The ventral subdivision of the central nucleus contained neurons similar to those found in the adjacent medial and lateral subdivisions. In addition, this subdivision contained a characteristic ovoid neuron with long, sparsely spinous dendrites. Vasoactive intestinal polypeptide (VIP) and neurotensin appeared to be present within this cell type. In the lateral capsular subdivision, neurotensin and enkephalin were present in cells resembling the medium spiny neurons characteristic of this part of the central nucleus. Numbers of spindle-shaped, biopolar somatostatin, and VIP neurons were identified in the medial, lateral, and ventral subdivisions. The present results provide evidence for a heterogeneous morphology of peptide-immunoreactive neurons in the rat central nucleus that are distributed across cytoarchitectonic boundaries. Except for substance P, neuropeptides in the central nucleus appear to be expressed by a variety of neurons rather than morphologically characteristic types of cell.
 ...
PMID:Morphology of peptide-immunoreactive neurons in the rat central nucleus of the amygdala. 246 96

The organization of neuroactive substances in the rat lateral geniculate body (LGB) was studied with available immunohistochemical stainings. In the dorsal lateral geniculate nucleus (DLG), there existed only gamma-aminobutyric acid (GABA)-like immunoreactive neurons. Immunoreactive fiber plexuses for substance P (SP), cholecystokinin-8 (CCK) and vasoactive intestinal polypeptide (VIP) were present in the lateral margin of the DLG, just beneath the optic tract. There were immunoreactive neurons and fibers for GABA, SP, leucine-enkephalin (ENK) and neuropeptide Y (NPY) in the intergeniculate leaflet (IGL). ENK-, NPY- and SP-like immunoreactive neurons in the IGL were mainly medium-sized, and bipolar or spindle-shaped with a few dendrites oriented dorsoventrally. In the IGL, use of double-labeled immunofluorescence demonstrated that a few neurons exhibited both ENK- and SP-like immunoreactivities, and a few neurons had both GABA- and ENK-like immunoreactivities. Although the morphology of ENK-like immunoreactive neurons resembled to NPY-like immunoreactive neurons, both neurons were clearly different neurons. Many GABA-, ENK- and SP-like immunoreactive neurons and fibers were found in the ventral lateral geniculate nucleus (VLG). These immunoreactive neurons were mainly medium-sized, and bipolar in shape, while a few immunoreactive neurons were of multipolar shape. Neurons containing ENK and fibers containing SP mainly existed in the lateral half of the parvocellular part and in the medial half of magnocellular part of the VLG. In this region, about one-third of the GABA-like immunoreactive neurons contained ENK-like immunoreactivity. Many SP neurons mainly existed in the medial half of the parvocellular part of the VLG. CCK- and VIP-like immunoreactive fibers were present in the lateral half of the magnocellular part of the VLG. Immunoreactive fibers for calcitonin gene-related peptide, corticotropin-releasing factor, neurotensin and tyrosine hydroxylase were disseminated throughout the LGB. The subdivisions of the LGB were discussed, based upon the distribution of neuroactive substances.
 ...
PMID:The organization of the rat lateral geniculate body by immunohistochemical analysis of neuroactive substances. 246 11

Coexistence of corticotropin releasing factor and neurotensin and also of substance P and somatostatin was demonstrated in the lateral bed nucleus of the stria terminalis and the central amygdaloid nucleus of the rat, by means of a light microscopic mirror method or immunofluorescent double staining. Using the former technique, a major proportion of corticotropin releasing factor-like immunoreactive cells were found to display neurotensin-like immunoreactivity in the dorsal subdivision of the lateral bed nucleus of the stria terminalis and the lateral subdivision of the central amygdaloid nucleus. On the other hand, the immunofluorescent method showed that a significant number of neurons with both substance P- and somatostatin-like immunoreactivity were located in the ventral subdivision of the lateral bed nucleus of the stria terminalis and the medial subdivision of the central amygdaloid nucleus. Distribution patterns of such co-localized peptides may indicate that there are morphological and biochemical similarities between the dorsal subdivision of the lateral bed nucleus of the stria terminalis and the lateral subdivision of the central amygdaloid nucleus, as well as between the ventral subdivision of the lateral bed nucleus of the stria terminalis and the medial subdivision of the central amygdaloid nucleus. Previous studies have demonstrated that peptide-containing neurons in the lateral bed nucleus of the stria terminalis and central amygdaloid nucleus, such as corticotropin releasing factor-, neurotensin-, substance P- and somatostatin-like immunoreactive cells, project to the lower brainstem. The results of the present study suggest that corticotropin releasing factor/neurotensin and substance P/somatostatin neurons may be part of the lateral bed nucleus of the stria terminalis/central amygdaloid nucleus-lower brainstem pathways.
 ...
PMID:Coexistence of peptides (corticotropin releasing factor/neurotensin and substance P/somatostatin) in the bed nucleus of the stria terminalis and central amygdaloid nucleus of the rat. 247 17

We have examined the distribution pattern and the density of various neuropeptide, neurotransmitter and enzyme containing neurons in the rat medial septum and the nucleus of the diagonal band of Broca to assess their possible involvement in the septohippocampal, septocortical and septobulbar pathways. Immunohistochemical methods were combined with the retrograde transport of a protein-gold complex injected in the hippocampus, the cingulate cortex or the olfactory bulb. Cholinergic neurons were the most numerous. Galanin-positive neurons were about two or three times less numerous than cholinergic cells. Both these cell types had a similar location though the choline acetyl transferase-like immunoreactive cells extended more caudally in the horizontal limb of the nucleus of the diagonal band of Broca. Immunoreactive cells for other neuroactive substances were few (calcitonin gene-related peptide, luteinizing hormone releasing hormone. [Met]enkephalin-arg-gly-leu) or occasional (dynorphin B, vasoactive intestinal polypeptide, somatostatin, neurotensin, cholecystokinin, neuropeptide Y and substance P). No immunoreactive cells for bombesin, alpha atrial natriuretic factor, corticotropin releasing factor, 5-hydroxytryptamine, melanocyte stimulating hormone, oxytocin, prolactin, tyrosine hydroxylase or arg-vasopressin were present. Choline acetyltransferase- and galanin-like immunoreactive cells densely participate to septal efferents. Cholinergic neurons constituted the bulk of septal efferent neurons. Galanin-positive cells were 22% of septohippocampal, 8% of septocortical, and 9% of septobulbar neurons. Galanin containing septohippocampal neurons were found in the medial septum and the nucleus of the diagonal band of Broca; galanin-positive septobulbar and septocortical cells were limited to the nucleus of the diagonal band of Broca. Occasional double-labellings were noticed with some peptides other than galanin. Luteinizing hormone-releasing hormone, calcitonin gene-related peptide and enkephalin were the most often observed; some other projecting cells stained for vasoactive intestinal polypeptide or dynorphin B. Luteinizing hormone-releasing hormone, calcitonin gene-related peptide and enkephalin were observed in septohippocampal neurons; luteinizing hormone-releasing hormone and vasoactive intestinal peptide were observed in septocortical neurons and calcitonin gene-related peptide, luteinizing hormone-releasing hormone and dynorphin B were observed in septo-bulbar cells. These results show that, in addition to acetylcholine, galanin is a major cellular neuroactive substance in septal projections to the hippocampus, the cingulate cortex and the olfactory bulb. The presence of septal projecting neurons immunoreactive for other peptides shows that a variety of distinct peptides may also participate, but in a smaller number, to septal efferent pathways.
 ...
PMID:Cholinergic and peptidergic projections from the medial septum and the nucleus of the diagonal band of Broca to dorsal hippocampus, cingulate cortex and olfactory bulb: a combined wheatgerm agglutinin-apohorseradish peroxidase-gold immunohistochemical study. 247 18

A cholinergic projection from the dorsolateral tegmentum to the medial anterior cortex has previously been shown to contain substance P and corticotropin releasing factor. Behavioral analysis of acetylcholine, substance P and corticotropin releasing factor microinjected into the medial anterior cortex revealed a seizure-related "boxing" behavior elicited by carbachol, which was potentiated by coinjection with substance P and antagonized by coinjection with corticotropin releasing factor. We now report that two antagonists of substance P receptors, [D-Pro2, D-Phe7, D-Trp9]-substance P and [D-Pro2, D-Trp7,9]-substance P, attenuate "boxing" behavior when coinjected with carbachol. Neither antagonist produced observable behavioral effects when microinjected alone. An analog of substance P, [pGlu,5, MePhe,8 Sar9]-substance P (5-11) potentiated carbachol-induced "boxing" at doses similar to naturally-occurring substance P. Monoclonal and polyclonal antisera against substance P were not effective antagonists of carbachol-induced "boxing." The ability of substance P antagonists to block carbachol-induced "boxing" has two major implications: (1) endogenous substance P may be modulating endogenous acetylcholine in the tegmental-cortical pathway; and (2) substance P antagonists may provide a new avenue for the development of antiepileptic drugs.
 ...
PMID:Substance P antagonists block carbachol-induced "boxing" behavior at a site of coexistence in the rat prefrontal cortex. 248 49


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>